Progress and potential: The Cancer Moonshot.
作者信息
Sharpless Norman E, Singer Dinah S
机构信息
National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.
National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.
出版信息
Cancer Cell. 2021 Jul 12;39(7):889-894. doi: 10.1016/j.ccell.2021.04.015. Epub 2021 May 6.
Abstract
摘要
相似文献
1
Progress and potential: The Cancer Moonshot.
Cancer Cell. 2021 Jul 12;39(7):889-894. doi: 10.1016/j.ccell.2021.04.015. Epub 2021 May 6.
2
The Moonshot Initiative and the Future of Cancer Research.
J Natl Cancer Inst. 2017 Dec 1;109(12). doi: 10.1093/jnci/djx276.
3
Cancer Moonshot: What It Means for Patients.
Clin J Oncol Nurs. 2017 Apr 1;21(2):141-142. doi: 10.1188/17.CJON.141-142.
4
What Biden's Presidency Will Mean for Cancer.
Cancer Discov. 2021 Mar;11(3):527-528. doi: 10.1158/2159-8290.CD-ND2021-0101. Epub 2021 Jan 20.
5
Supporting 'team science' to achieve ambitious Cancer Moonshot goals.
Mod Healthc. 2016 Aug;46(33):25.
6
US Cancer Moonshot must strike a balance between research and prevention.
Nature. 2016 Nov 24;539(7630):467. doi: 10.1038/539467a.
7
Proposed US Government budget cuts would 'devastate' cancer research.
Lancet Oncol. 2017 May;18(5):577. doi: 10.1016/S1470-2045(17)30236-X. Epub 2017 Mar 23.
8
The US cancer moonshot-A need and opportunity for primary care participation and collaboration.
Eur J Cancer Care (Engl). 2017 May;26(3). doi: 10.1111/ecc.12716. Epub 2017 May 16.
9
A new initiative on precision medicine.
N Engl J Med. 2015 Feb 26;372(9):793-5. doi: 10.1056/NEJMp1500523. Epub 2015 Jan 30.
10
Precision medicine and the cancer "moonshot.".
MLO Med Lab Obs. 2016 Aug;48(8):56.
引用本文的文献
1
Sharing data from the Human Tumor Atlas Network through standards, infrastructure and community engagement.
Nat Methods. 2025 Apr;22(4):664-671. doi: 10.1038/s41592-025-02643-0. Epub 2025 Mar 31.
2
Mapping the landscape and research trend of imaging diagnosis in lymphoma: a bibliometric analysis from 1976 to 2024.
Front Med (Lausanne). 2025 Jan 29;12:1516817. doi: 10.3389/fmed.2025.1516817. eCollection 2025.
3
Extending the translational science benefits model to implementation science for cancer prevention and control.
J Clin Transl Sci. 2024 Nov 5;8(1):e211. doi: 10.1017/cts.2024.582. eCollection 2024.
4
Anti-EGFR aptamer exhibits direct anti-cancer effects in NSCLC cells harboring EGFR L858R mutations.
NPJ Precis Oncol. 2024 Nov 21;8(1):271. doi: 10.1038/s41698-024-00758-9.
5
Navigating the Landscape of Cancer From Ancient Times to Modern Challenges: A Narrative Review.
Cureus. 2024 Jul 23;16(7):e65230. doi: 10.7759/cureus.65230. eCollection 2024 Jul.
6
Initiation of Cancer: The Journey From Mutations in Somatic Cells to Epigenetic Changes in Tissue-resident VSELs.
Stem Cell Rev Rep. 2024 May;20(4):857-880. doi: 10.1007/s12015-024-10694-7. Epub 2024 Mar 8.
7
Integration of Computational Docking into Anti-Cancer Drug Response Prediction Models.
Cancers (Basel). 2023 Dec 21;16(1):50. doi: 10.3390/cancers16010050.
8
The Cancer Moonshot, the role of in vitro models, model accuracy, and the need for validation.
Nat Nanotechnol. 2023 Oct;18(10):1121-1123. doi: 10.1038/s41565-023-01486-0.
9
Local Social Vulnerability as a Predictor for Cancer-Related Mortality Among US Counties.
Oncologist. 2023 Sep 7;28(9):e835-e838. doi: 10.1093/oncolo/oyad176.
10
Enhancing social value considerations in prioritising publicly funded biomedical research: the vital role of peer review.
J Med Ethics. 2024 Mar 20;50(4):253-257. doi: 10.1136/jme-2022-108883.
本文引用的文献
1
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts.
Nat Genet. 2021 Jan;53(1):86-99. doi: 10.1038/s41588-020-00750-6. Epub 2021 Jan 7.
2
The nucleosome acidic patch and H2A ubiquitination underlie mSWI/SNF recruitment in synovial sarcoma.
Nat Struct Mol Biol. 2020 Sep;27(9):836-845. doi: 10.1038/s41594-020-0466-9. Epub 2020 Aug 3.
3
Pragmatic cluster randomized trial to evaluate effectiveness and implementation of enhanced EHR-facilitated cancer symptom control (E2C2).
Trials. 2020 Jun 5;21(1):480. doi: 10.1186/s13063-020-04335-w.
4
Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia.
Sci Transl Med. 2020 Jun 3;12(546). doi: 10.1126/scitranslmed.aaz0463.
5
A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors.
Nat Med. 2020 May;26(5):792-802. doi: 10.1038/s41591-020-0844-1. Epub 2020 May 11.
6
Tuning the Antigen Density Requirement for CAR T-cell Activity.
Cancer Discov. 2020 May;10(5):702-723. doi: 10.1158/2159-8290.CD-19-0945. Epub 2020 Mar 19.
7
Systematic Establishment of Robustness and Standards in Patient-Derived Xenograft Experiments and Analysis.
Cancer Res. 2020 Jun 1;80(11):2286-2297. doi: 10.1158/0008-5472.CAN-19-3101. Epub 2020 Mar 9.
8
Pathway-guided analysis identifies Myc-dependent alternative pre-mRNA splicing in aggressive prostate cancers.
Proc Natl Acad Sci U S A. 2020 Mar 10;117(10):5269-5279. doi: 10.1073/pnas.1915975117. Epub 2020 Feb 21.
9
Highly multiplexed immunofluorescence images and single-cell data of immune markers in tonsil and lung cancer.
Sci Data. 2019 Dec 17;6(1):323. doi: 10.1038/s41597-019-0332-y.
10
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma.
Nat Med. 2019 Dec;25(12):1916-1927. doi: 10.1038/s41591-019-0654-5. Epub 2019 Dec 2.
Zotero 插件